Industry News for MS
Find the latest news and headlines on new drug discoveries, healthcare research, and development.
Press Release: New 48-Week Frexalimab Phase 2 Data Support Potential For High Sustained Efficacy In Multiple Sclerosis
New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis Data support frexalimab as a [...]
The Siegel Rare Neuroimmune Association Marks 30 Years of Improving Quality of Life for People With Rare Neuroimmune Disorders
Not-for-profit celebrates past achievements and looks to the future POWELL, Ohio, February 29, 2024 (Newswire.com) - The Siegel Rare [...]
The Language of MS: How Much Does It Matter?
I got an email recently from someone well up the chain of command at a multiple sclerosis (MS) patient advocacy organization. The purpose [...]
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete [...]
Positive Phase III results for Genentech’s Ocrevus (ocrelizumab)
Phase III OCARINA II trial met primary and secondary endpoints Ocrevus 10-minute injection has the potential to further improve the [...]
Helius launches UpScript telehealth e-commerce site
PDF Version New Partnership with UpScript Provides Access to Care, Delivers PoNS Devices to Doorsteps NEWTOWN, Pa., Jan. 03, 2023 [...]
Cycle Pharmaceuticals to launch TASCENSO ODT® (fingolimod) in US in Q1 2023
Eligible patients will receive full MS patient support program through Cycle Vita™ Boston, Massachusetts and San Jose, California – [...]
Genentech to present new Ocrevus (ocrelizumab) data in multiple sclerosis & NMOSD research at ECTRIMS
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® (ocrelizumab) data and continued [...]
US FDA – Ocrevus prescribing information to include warnings for Colitis and PML
Labeling updates to Ocrevus (ocrelizumab) injection, for intravenous use for the treatment of multiple sclerosis (MS) will be [...]
Janssen Pharmaceuticals U.S. transparency report
Janssen Pharmaceuticals recently published their sixth annual Janssen U.S. Transparency Report. The Report explains Janssen’s sustained [...]
Genentech premiers #MSVisibility 2022
Genentech is very excited to kick off #MSVisibility 2022 this coming Monday, March 28th with the launch of a new, bilingual video, focusing [...]
Sanofi’s 2022 annual pricing principles report
I’m pleased to share with you Sanofi’s 2022 Annual Pricing Principles report. This is the sixth consecutive edition of this [...]
New preclinical tolebrutinib data demonstrated superior brain penetration and potency
Preclinical findings showed that tolebrutinib, among the investigational BTK inhibitors tested, had the best combination of brain [...]
Study: Epstein-Barr virus can cause multiple sclerosis
Researchers from Harvard University recently found that the Epstein-Barr virus (EBV), which is most known for leading to mononucleosis, is [...]
Ublituximab, potential relapsing multiple sclerosis therapy, up for FDA approval
TG Therapeutics has applied to the U.S. Food and Drug Administration (FDA) for approval of ublituximab, the company’s investigational [...]
Introducing Atara Biotherapeutics: the role of EBV in multiple sclerosis and the Phase II EMBOLD study
Consortium of Multiple Sclerosis Centers (CMSC) and Atara Biotherapeutics on Thursday - June 10, 2021 at 7:00 PM - 8:00 PM ET on an [...]
Study on cognitive processing speed changes in RMS subjects treated with Ozanimod
Bristol Myers Squibb is conducting a Phase 3b Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing [...]
#MSVisibility virtual concert: recording now available
#MSVisibility Virtual Concert Thank you for your interest in the first-ever #MSVisibility Virtual Concert, a free event to celebrate and [...]
Phase 1/2 study to evaluate the safety and efficacy of ATA188 in progressive multiple sclerosis
The purpose of this study is to evaluate the safety and tolerability of ATA188 as a monotherapy in Parts 1 and 2, to determine the [...]
New data for Ocrevus disease progression (ocrelizumab) reinforce significant slowing
– 85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no evidence of disease activity [...]
New Genentech data at 2021 AAN highlight impact & breadth of neuroscience portfolio
Evrysdi (risdiplam) 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy [...]
Janssen announces U.S. FDA approval of PONVORY™ (ponesimod)
Head-to-head pivotal clinical trial results showed PONVORY™ treatment led to nearly a third fewer annual relapses than [...]
FDA approval of intramuscular Plegridy (Peginterferon beta-1a)
Please be advised of the recent approval by the FDA for intramuscular Plegridy (Peginterferon beta-1a) and an update to other sections [...]
Dr. Thrower discusses management, different types of multiple sclerosis fatigue
https://youtu.be/vtwauNrp8Jo Ben Thrower, MD, Medical Director, Andrew C. Carlos Multiple Sclerosis Institute, talks about different [...]
New data further reinforce Genentech’s Ocrevus (ocrelizumab) as effective treatment
7 5% of patients with relapsing-remitting multiple sclerosis (RRMS) and suboptimal response to prior treatment had no evidence of disease [...]
Genentech’s enspryng for Neuromyelitis Optica Spectrum Disorder
First and only FDA-approved subcutaneous treatment option for anti-aquaporin-4 antibody positive NMOSD that can be self-administered by a [...]
Mylan brings critical access to the multiple sclerosis community
HERTFORDSHIRE, England, and PITTSBURGH– August 19, 2020 – Mylan N.V. (NASDAQ: MYL) today announced the launch of the first [...]
A letter from Lemtrada regarding its home phlebotomy partner, EMSI
Good Day Lemtrada Patient – On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination [...]
Inebilizumab approved for treatment of Neuromyelitis Optica Spectrum Disorder
The US FDA has approved inebilizumab for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults who are anti-aquaporin-4 [...]
Rebif® U.S. label includes pregnancy outcomes & lactation information
- Label update is based on data from a large register-based study, as well as other published studies over several decades - Multiple [...]
Avonex and Plegridy label updates
The Plegridy (peginterferon beta-1a) Prescribing Information and the Avonex (interferon beta-1a) Prescribing Information was updated in the [...]
FDA approves Zeposia (Ozanimod), oral therapy for all with relapsing multiple sclerosis
The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms [...]
MedDay report top-line data from trial “SPI2” for treatment of progressive forms of multiple sclerosis
Paris, France, March 10, 2020 – MedDay Pharmaceuticals announced today that the second pivotal Phase III trial (SPI2) of its [...]
U.S. health officials urge Americans to prepare for spread of Coronavirus
CHICAGO/WASHINGTON (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted Americans to begin preparing [...]
Participate in a study evaluating a potential treatment options for RRMS relapses
The OPTIONS Study is looking at how well a study drug works for adults with relapsing-remitting multiple sclerosis (RRMS) who are currently [...]
Brain activity patterns linked with improved learning and memory in multiple sclerosis
A recent article by Kessler Foundation researchers demonstrated g people with multiple sclerosis (MS). The article, "Brain activation [...]
Robotic ‘trousers’ could help thousands of multiple sclerosis sufferers stand and walk again
Robotic ‘trousers’ could help thousands of people left unable to stand or walk due to multiple sclerosis find their feet again. The [...]
Use of DMTs changing ‘natural history’ of relapsing multiple sclerosis, study says
People with relapsing multiple sclerosis (MS) have a better prognosis and a slower progression to disability since the introduction of [...]
FDA approves first generics for common multiple sclerosis drug
The FDA has approved 3 applications for generics of fingolimod (Gilenya, Novartis). These are the first generics of the drug, which treats [...]
Results for Genentech’s Satralizumab in Neuromyelitis Optica Spectrum
Satralizumab demonstrated robust efficacy, sustained for 144 weeks, in significantly reducing the risk of relapse in combination with [...]
NeurologyLive™ adds CMSC to its Strategic Alliance Partnership program
CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive™, a multimedia platform dedicated to providing health care professionals treating [...]
Kessler scientists receive grant to study exercise benefits in multiple sclerosis
East Hanover, NJ. October 7, 2019. With a grant from the Consortium of Multiple Sclerosis Centers, John DeLuca, PhD, Helen Genova, PhD, of [...]
EMD Serono initiates pivotal Phase III program for investigational Evobrutinib in RMS
ROCKLAND, Mass., Sept. 10, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. [...]
Genentech presents new six-year Ocrevus (Ocrelizumab) data
Post-hoc analysis from a Phase III open-label extension study showed a 42% reduction in the risk of PPMS patients needing a wheelchair [...]
Genentech’s Satralizumab significantly reduced relapse risk
Pivotal Phase III SAkuraStar study shows 55% reduction in the risk of relapse for satralizumab monotherapy versus placebo presented at [...]
Genentech presents new Ocrevus (Ocrelizumab) biomarker data
Blood neurofilament light chain (NfL) levels were significantly lowered following Ocrevus treatment in analyses of Phase III studies in RMS [...]
Dr. Daniel Kantor highlights multiple sclerosis treatments and what is in the pipeline
The field of treatments for multiple sclerosis (MS) has grown quickly in the last 30 years, but the next new class of therapies probably [...]
Multiple sclerosis relationships improved by togetherness and communication, study suggests
Relationships between multiple sclerosis patients and their intimate partners were enhanced when the couple worked together to make [...]
Press release – Genentech to present piviotal data at ECTRIMS
Investigational medicine satralizumab significantly reduces the risk of relapse in pivotal SAkuraStar monotherapy study for neuromyelitis [...]
Social cognition, mood and fatigue in multiple sclerosis
Study by MS research team links deficits in social cognition with fatigue, depressive symptomatology, and anxiety Date: August 29, [...]
The genetic and environmental factors that can cause multiple sclerosis
Researchers say genetic makeup is a factor, but so are smoking, obesity, vitamin D, and viral infections. A combination of genetic and [...]
Rutgers Health leading program to support multiple sclerosis children
Rutgers Health is leading the Pediatric Multiple Sclerosis and Demyelinating Diseases Program, the only program in the state of New [...]
Dr. Anne Cross discusses strides In multiple sclerosis research, recent award
Years ago, when many multiple sclerosis researchers believed that a type of immune cell known as a T-cell was the cause of the disease, Dr. [...]
EMD Serono’s embracing carers launches ‘Time Counts’ to raise 1M minutes of support
Rockland, MA – EMD Serono, the biopharmaceutical company of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that [...]
Alexion’s Soliris gets new, and lucrative, rare disease indication
June 28, 2019 (This news originally appeared in PharmaPhorum Website [...]
Kessler researchers explore social cognitive deficits in progressive multiple sclerosis
East Hanover, NJ. June 25, 2019. A recent study by Kessler Foundation researchers provided new findings about the nature of social [...]
Billings Clinic hosts its first multiple sclerosis health and well-being symposium
The Billings Clinic hosted its first Multiple Sclerosis Health and Well-Being Symposium. It was a day-long educational seminar for people [...]
Study moves closer to identifying cause of multiple sclerosis
A study by the University of British Columbia made a scientific advance that researchers hope will lead to the development of preventative [...]
UCLA researchers work to advance treatment targeting source of multiple sclerosis
UCLA researchers are developing the first multiple sclerosis treatment that could target the cause of the disease, instead of simply [...]
Genentech presenting new Ocrevus (Ocrelizumab) data at AAN Meeting
Genentech to Present New OCREVUS (ocrelizumab) Data Analyses Showing Significant Reduction of Disability Progression in Relapsing and [...]
MSAA recognizes ten years of artwork from individuals with multiple sclerosis
CHERRY HILL, N.J., May 2, 2019 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to recognize ten years of [...]
FDA approves MAVENCLAD® (Cladribine) tablets
- MAVENCLAD is the first oral MS treatment to provide two years of proven efficacy with a maximum of 20 days of treatment - MAVENCLAD's [...]
OHSU doctors part of ‘breakthrough’ research on treating multiple sclerosis
PORTLAND, Ore. (KATU) – They're calling it a potential game-changer. Doctors at Oregon Health and Science University are part of a new [...]
Anne Cross, neurologist with pioneering work into B-cells/multiple sclerosis, awarded John Dystel Prize
This year’s John Dystel Prize for Multiple Sclerosis Research is being awarded to Anne H. Cross, a neurologist and MS chair in the [...]
Novartis gets FDA approval for Mayzent (Siponimod), the first oral drug to treat SPMS
EAST HANOVER, N.J., March 27, 2019 /PRNewswire/ --Novartis today announced that the US Food and Drug Administration (FDA) has approved [...]
Novartis receives FDA approval for MAYZENT (Siponimod)
- Mayzent® (siponimod) is the first and only oral treatment specifically indicated for active secondary progressive multiple sclerosis [...]
Dose-finding study for SAR442168 in relapsing multiple sclerosis
Brief Summary: Primary Objective: To determine the efficacy of SAR442168 in reducing the number of new brain lesions reported in [...]
BrainStorm announces first patient in phase 2 clinical trial progressive multiple sclerosis
NEW YORK and CLEVELAND, March 14, 2019 (GLOBE NEWSWIRE)—BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing [...]
Depression, psychological distress symptoms affect multiple sclerosis patients’ quality of life
Depression and psychological distress symptoms can have a huge effect on the way multiple sclerosis (MS) patients view their well-being, [...]
FDA accepts BrainStorm’s NurOwn® IND application for progressive multiple sclerosis
NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative [...]
Positive late-breaking phase II data evaluating investigational oral therapy
First Bruton’s Tyrosine Kinase inhibitor (BTKi) demonstrating clinical proof-of-concept in relapsing multiple sclerosis (RMS) [...]
TG Therapeutics, Inc. announces final phase 2 multiple sclerosis data presentation at ECTRIMS
Annualized Relapse Rate (ARR) of 0.07 observed for all patients on Phase 2 trial ECTRIMS data review conference call to be held [...]
Novartis announces FDA filing acceptance of Siponimod (BAF312)
There is a critical need for safe and effective treatments for secondary progressive multiple sclerosis (SPMS), a highly debilitating [...]
New efficacy and safety data on multiple sclerosis portfolio to be presented
Late-breaking Phase II primary endpoint data for investigational therapy evobrutinib, the first oral BTK inhibitor to show [...]
Press release – Ocrevus data show early initiation reduces progression
Dear Advocates, OCREVUS (Ocrelizumab) Data Show Early Initiation of Treatment Reduces Disability Progression over Five Years in [...]
Novartis announces PARADIGMS study demonstrating benefit of Gilenya®
Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya® in children and adolescents [...]
Researchers identify new subtype of multiple sclerosis
Researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the disease and potentially [...]
MRI tests may help doctors predict multiple sclerosis progression in patients
Researchers have apparently found a way to help predict multiple sclerosis disease progression one year after an initial [...]
Researchers have a new theory about what may cause multiple sclerosis
When the following headline in the Australian newspaper the Herald Sun caught my eye recently, I was cautiously intrigued: “Doctors [...]
FDA accepts file for Cladribine tablets as potential treatment for relapsing forms of multiple sclerosis
PDF ROCKLAND, Mass., July 30, 2018 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and [...]
Temperament can play a big role in quality of life with multiple sclerosis
Researchers say if a person with multiple sclerosis is irritable or anxious, it can make overcoming the obstacles of their disease much [...]
Genentech announces new Ocrevus (Ocrelizumab) data for PPMS
Dear Advocates, We are pleased to announce that new OCREVUS® (ocrelizumab) data will be presented at the 4th Congress of the European [...]
AAN publishes guideline on disease-modifying therapies for multiple sclerosis
The AAN published a new guideline, Practice Guideline: Disease-modifying Therapies for Adults with Multiple Sclerosis, in Neurology® [...]
New Ocrevus (Ocrelizumab) data demonstrate reductions In activity & progression In RMS
We are pleased to announce that new OCREVUS® (ocrelizumab) data were presented at the 70th American Academy of Neurology (AAN) Annual [...]
Phase III data in the lancet show Novartis outcomes in secondary progressive multiple sclerosis
EAST HANOVER, N.J., March 22, 2018 – Novartis today announced that the full results from the Phase III EXPAND study of oral, [...]
Abbvie and Biogen pull multiple sclerosis drug Zinbryta following urgent EMA safety review
Seven of the cases were identified in Germany and one in Spain, and included encephalitis and meningoencephalitis. The pharma pair said in [...]
CVS/Aetna combo a formidable pharma rival when it comes to access
Last month's unusual consolidation of healthcare provider CVS Health with insurance company Aetna spawned a new behemoth that could pose a [...]
Fruits and vegetables may help reduce symptoms of multiple sclerosis: study
Eating a healthy diet containing loads of fruits and vegetables along with whole grains may lower disability and reduce symptoms of [...]
Increased epilepsy risk identified in multiple sclerosis
A direct correlation exists between the presence and severity of multiple sclerosis (MS) and the risk for epilepsy, according to study [...]
National Multiple Sclerosis Society endorses multiple sclerosis “NARCRMS” data registry
NEW YORK, Dec. 4, 2017 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society is proud to announce its endorsement of [...]
Mayo Clinic develops test to distinguish other demyelinating diseases from multiple sclerosis
The Mayo Clinic has developed a test that allows doctors to distinguish other inflammatory demyelinating diseases from multiple sclerosis [...]
Cognitive impairment worse among PPMS than RMS patients, German study fnds
Patients with primary progressive multiple sclerosis (PPMS) have more severe cognitive impairment than those with relapsing-remitting [...]
5 areas of research that could change the future of multiple sclerosis treatment
Multiple sclerosis is a disease that affects the nervous system, disrupting messages between the brain and the rest of the body resulting [...]
Breastfeeding linked to reduced risk of multiple sclerosis – study
New York: Mothers who breastfeed for at least 15 months over one or more pregnancies may be 53 per cent less likely to develop multiple [...]
12 ways amazon’s alexa can help people with multiple sclerosis
“Alexa” is Amazon’s talking service that acts as a virtual personal assistant. According to tomsguide.com, as part of the company’s [...]
OMRF multiple sclerosis center wins top multiple sclerosis research award
OKLAHOMA CITY — The Oklahoma Medical Research Foundation's Multiple Sclerosis Center of Excellence won the Labe Scheinberg Award at the [...]
Minocycline may slow progression from Clinically Isolated Syndrome to multiple sclerosis
Minocycline, a broad-spectrum tetracycline antibiotic, reduces risk of conversion from clinically isolated syndrome (CIS) to multiple [...]
Multiple aclerosis – antioxidant may slow disease progression
In a pilot study, researchers found that taking a high dose of lipoic acid every day for 2 years reduced whole brain atrophy among patients [...]
Research sheds light on who’s multiple sclerosis could worsen
A preliminary study by senior author Bianca Weinstock-Guttman, MD, has heightened researchers’ understanding about which adults with [...]
Sodium intake and its association with multiple sclerosis progression
HealthDay News — There is no association between average 24-hour urine sodium levels and conversion from clinically isolated syndrome [...]
New multiple sclerosis drug, backed by 40 years of research, could halt disease
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis (MS) is holding new hope for [...]
‘MS From the Inside Out’ uses virtual reality to share what life for patients is like
Virtual reality (VR) technology is most commonly associated with gaming and entertainment, but it’s expanding into a variety of clinical [...]
Multiple sclerosis study in cancer breakthrough
A DRUG that helps the immune system destroy cancer has been developed by US scientists. It dramatically shrank deadly skin, brain and [...]
Multiple sclerosis is more complex than once thought: study
Having a disabling disease can making living very difficult, especially when the source of the disability is not well understood. Some [...]
Multiple sclerosis starts five years before onset of disease, study suggests
Symptoms of multiple sclerosis (MS) can appear 5 years before onset of the disease, according to a new study published in Lancet [...]
The hidden costs of multiple sclerosis
MS is sneaky. It is expert at evading detection and diagnosis, and often brings a host of invisible symptoms that may come and go at [...]
What triggers multiple sclerosis? scientists may have identified the culprit
Scientists have identified a cellular mechanism that may be responsible for the development of multiple sclerosis (MS), and could serve as [...]
Vitamin D deficiency affects cognition in multiple sclerosis
Results of a study published in a recent issue of Scientific Reports1 showed significant improvements in cognitive performance among [...]
Nose2brain – project to improve multiple sclerosis therapy
Medically active substances are usually distributed via the blood – either directly or indirectly. In many diseases, however, it is vital [...]
Biogen Idec to present new two-year data from the PLEGRIDY phase 3 advance study
Biogen Idec to Present New Two-Year Data from the PLEGRIDY™ (Peginterferon Beta-1a) Phase 3 Advance Study at AAN Annual [...]
New survey finds multiple sclerosis patients struggle with misdiagnosis and invisible symptoms
PHILADELPHIA, PA --(Marketwired - April 27, 2017) - MS in America 2017, a national survey of more than 5,300 individuals diagnosed with [...]
Why the future of science is crucial to the multiple sclerosis community
Everything around us, and within us, begins with science. Science is important to the future of humanity’s well-being. Science is what [...]
Is ‘no evidence of disease activity’ a misnomer in multiple sclerosis?
BOSTON -- Multiple sclerosis patients who are not having relapses, not becoming more disabled according to a standard measure, and with MRI [...]
How biotech is mastering multiple sclerosis: a review
Multiple sclerosis (MS) is an autoimmune disease that affects the nervous system, and around 2 million people around the world live with [...]
Health reform: how is pharma affected?
Reforming the health care industry is an increasingly complex challenge due to multiple layers of legislation already in place and the [...]
Brain protein may unlock key to multiple sclerosis treatment – study
Scientists have made significant progress in finding the cause of multiple sclerosis (MS), discovering the presence of a protein in brain [...]
Research moves closer to unraveling mystery cause of multiple sclerosis
A new study has made a major new discovery towards finding the cause of multiple sclerosis (MS), potentially paving the way for research to [...]
Glove with sensors measures spasticity more accurately than physicians
A multidisciplinary team at the University of California at San Diego has come up with a computerized glove used as a sensor to measure [...]
Symptoms of multiple sclerosis start to show five years before its onset
People with multiple sclerosis start showing its symptoms five years before the onset of the disease, claim Canadian [...]
Researchers analyze multiple sclerosis life expectancy, survival and mortality in 60-year study
A 60-year longitudinal multiple sclerosis (MS) study in a Norwegian cohort analyzing life expectancy, survival and mortality concluded that [...]
Alexa, tell me about multiple sclerosis
Alexa, Amazon’s little voice-activated information box, has just received a multiple sclerosis infusion. As part of MS Awareness [...]
Pilot study may lead to telemedicine benefiting people with multiple sclerosis
Telemedicine, which allows healthcare professionals to evaluate, diagnose and treat patients at a distance with telecommunications [...]
Researchers make major brain repair fiscovery in fight against multiple sclerosis
The research study, led by Dr Yvonne Dombrowski and Dr Denise Fitzgerald at the Wellcome-Wolfson Institute for Experimental Medicine at [...]
5 benefits of having a pet when you have multiple sclerosis
As part of MS Awareness Month, we’re looking at different aspects of living with multiple sclerosis and some of the things patients [...]
Here’s How You Can Prevent, Manage Multiple Sclerosis
Multiple Sclerosis (MS) is a chronic disease that affects around 2.3 million people worldwide and can cause blurred vision, slurred speech, [...]
How Stress Affects Multiple Sclerosis Symptoms
As part of MS Awareness Month, we want to talk about the role stress plays in multiple sclerosis. Having any chronic illness is likely to [...]
Horseback Riding Helps People with Movement Disabilities, Review of 16 Studies Concludes
Riding and other activities with horses can help adults and children with the balance, gait, and psychomotor disorders that are hallmarks [...]
People with MS are Three-six Times More Prone to Seizures than Others, Study Reports
People with multiple sclerosis (MS) are three to six times more likely to develop epilepsy than the general population, a study [...]
Multiple Sclerosis – New Technology Improves Cognition
Multiple sclerosis (MS) is an often disabling neurological disease that affects one's muscles, vision, mood, and concentration. MS is [...]
11 Subtle Early Signs of Multiple Sclerosis – The Sooner You Catch it the Better
Multiple sclerosis is one of those scary health concerns that rarely comes up in conversation. And yet, learning about and recognizing the [...]
HackensackUMC Opens Multiple Sclerosis Center
Hackensack University Medical Center has opened a new multiple sclerosis center. “We are very excited to offer a comprehensive center [...]
First Blood Biomarker for Multiple Sclerosis Discovered
Although there is no known cure for multiple sclerosis (MS), there are treatments that can help prevent new attacks and improve function [...]
MS – New Blood Test Can Identify Types of MS and if Treatments are Working
At the moment, patients have to have an array of expensive tests to determine what kind of MS they have. The study, published in Nature [...]
Generic Form of Copaxone, GTR, Safe and Effective, Study Confirms
An extension trial assessing generic glatiramer acetate (GTR) treatment in multiple sclerosis (MS) patients found that the formulation is [...]
Researchers fFnd Clues to Multiple Sclerosis in Blood
In a new study led by Indian-American researchers at Brigham and Women’s Hospital, Harvard Medical School, suggests that microRNAs in the [...]
Sense of Smell is Impaired in Half of Multiple Sclerosis Patients in Study
Many multiple sclerosis (MS) patients have a reduced sense of smell, and the more relapses they have, the worse the problem, according to a [...]
Epileptic Seizures in Multiple Sclerosis May Suggest Shared Pathology
Patients with multiple sclerosis (MS) who experience seizures are more likely to be younger at the age of MS onset than patients with MS [...]
Grief, Self-Preservation and Multiple Sclerosis
Grief can weaken our immune system, elevate our blood pressure, and affect our overall health. During a loss, especially one of the [...]
Template Improves Quality of Report on MRI for Multiple Sclerosis
Use of a standardized template for reporting of brain magnetic resonance images (MRIs) in patients with multiple sclerosis (MS) improves [...]
Ocrelizumab Shown Effective Against Relapsing, Progressive Forms of Multiple Sclerosis
The drug ocrelizumab was found effective in the treatment of multiple sclerosis in three different large-scale, multi-center trials [...]
21st Century Cures Act Expected to Bring Real Change to MS patients’ Lives
President Obama’s signing of the 21st Century Cures Act on Dec. 13 is expected to bring real change to those living with multiple [...]
Multiple Sclerosis – Better Ways to Test Diet Changes
Will a Mediterranean-style, non-dairy, low-carb diet improve symptoms for patients with multiple sclerosis (MS)? Helping MS patients by [...]
Imbalances in Brain Microbiota May be Behind Demyelination in MS, Study Says
Alterations in microorganisms in the brains of multiple sclerosis (MS) patients could contribute to underlying disease mechanisms, [...]
Low Vitamin D Levels at Birth May Influence MS Risk in Adults, Study Suggests
The risk of developing multiple sclerosis (MS) later in life may be higher for babies born with low levels of vitamin D, according to a [...]
ICER Releases Draft Report on Disease-Modifying Therapies for MS, Welcomes Comment
The Institute for Clinical and Economic Review (ICER) has released a Draft Evidence Report evaluating the comparative clinical [...]
UV Light May Lead Way to New Treatment for MS and Inflammation
Researchers have found a way to harness inflammation with the help of ultraviolet (UV) light, making it possible to design an [...]
Acorda to Discontinue Dalfampridine for Treatment of Post-Stroke Walking Difficulties
ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the MILESTONE clinical study did not show [...]
Genentech Results from Survey that Shows Everyday Impact of Unpredictable MS Symptoms
Jesse met his wife at a college dance. When they first started dating, she told him that she had multiple sclerosis (MS), a disease of the [...]
Men & Women Seem to Differ in Genetic Susceptibility to MS & its Progression in Study
Researchers in Russia found for a first time an association between variants in GAL, a gene that codes for the galanin protein, and [...]
Immune System May Harbor Natural Way of Fighting MS, Other Autoimmune Diseases
A variant in the TYK2 gene, which encodes an immune system protein, may work to protect people from autoimmune disorders, including [...]
Posture Difficulties in MS Linked to Areas of Nervous System Most Damaged by Disease
Posture control is a complex skill, requiring different areas of the nervous system to work well and to work together — but the damage [...]
‘Rare’ Molecule in Immune System is Common and May be Part of What Goes Wrong in MS
Researchers have discovered that a type of immune molecule — called “spliced epitopes,” once believed to be very rare — in fact [...]
Selective Manipulation of Specific Receptors May Pave Way for New MS Therapies
Mouse experiments with compounds having opposite actions on two receptors for TNF (tumor necrosis factor) — a key factor in [...]
Multiple Sclerosis Drug Could Reverse Physical Symptoms
Multiple sclerosis (MS) is estimated to affect 2.3 million individuals worldwide. The majority of people with MS are initially diagnosed [...]
Multiple Sclerosis Research Finds Running ‘Could Help Prevent’ Notorious Disease
For years, health advocates have urged the public to abandon their sedentary lifestyle and adopt a more active daily routine. Recently, a [...]
Daclizumab Approved (zinbryta tm) for Relapsing Forms of Multiple Sclerosis
The DECIDE trial compared daclizumab 150mg subcutaneous injection every 4 weeks with interferon (INF) beta-1a (Avonex) 30mcg once weekly [...]
Scientists Develop System for Early Diagnosis of Parkinson’s, MS, and Alzheimer’s
Virtual reality diagnosis using a new mathematical model linked to balance can detect first signs of these disorders, it is [...]
Tysabri May be More Effective than Gilenya at Reducing Disease Activity in MS Patients
An indirect comparison of results from randomized clinical trials in relapsing-remitting multiple sclerosis (RRMS) patients suggests [...]
Lifelong Exercise Doesn’t Lower the Risk of MS, Large Study in Women Reports
In a large prospective study with validated measures of physical activity, researchers found no evidence that exercise reduced a woman’s [...]
Satisfaction with MS Therapy Influenced by Doctor-Patient Communication, Study Finds
A study published in the BMC Neurology journal emphasized that clear and regular communication between physicians and patients with [...]
MS More Frequent Among Females Exposed to High Levels of Copper, Study Shows
Exposure to heavy metals and being female are associated with a higher incidence of multiple sclerosis (MS), according to a study conducted [...]
How Tecfidera Works to Reduce MS Relapses Discovered, May Lead to Better Treatments
How the multiple sclerosis (MS) therapy Tecfidera (dimethyl fumarate) works on a molecular level has finally been uncovered, using a new [...]
Protein Biomarker Identified for MS May Predict Disease Severity, Treatment Response
A newly discovered potential biomarker of multiple sclerosis (MS) may help to distinguish between people who will go on to have less severe [...]
Experimental Drug May Prevent Development of Multiple Sclerosis in Mice
The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to [...]
8 less common symptoms of multiple sclerosis
Multiple sclerosis (MS) results when the body’s immune system starts to attack and destroy myelin, the protecting coating on nerve fibers [...]
Can multiple sclerosis be detected by biomarkers in the blood? yes, study says
MicroRNAs present in the blood show promise as potential biomarkers of multiple sclerosis (MS), a new study suggests. The study, titled [...]
Multiple sclerosis diagnosis and treatment: scientist challenge study linking gene to the condition
Last June, a study came out in Neuron that a gene is responsible for multiple sclerosis. That gene has been identified as NR1H3 by Dr. [...]
Multiple sclerosis treatments may lower levels of immune white blood cells
Multiple sclerosis patients are at risk of developing lymphopenia, or abnormally low levels of immune defense white blood cells, called [...]
Blood test seen to distinguish multiple sclerosis from other neurological conditions
Researchers at Michigan State University suggest that a blood test can distinguish patients with multiple sclerosis (MS) from people with [...]
Specific definition of fatigue in multiple sclerosis proposed as way to advance research into symptom
Researchers from Colorado State University propose a new model of fatigue in multiple sclerosis (MS), designed to overcome the lack of a [...]
Researchers develop technology for treating multiple sclerosis with gaming cameras
Using a gaming camera that detects movement and computer algorithms that quantify people’s walking patterns can help clinicians [...]
Alleviating multiple sclerosis symptoms possible with yoga and aquatic exercises
Multiple sclerosis (MS) symptoms such as fatigue, depression, and paresthesia can be alleviated using yoga and aquatic exercises, according [...]
Early treatment of multiple sclerosis (MS) symptoms extends diagnosis time
Beginning multiple sclerosis (MS) treatment at the early stage of symptoms may delay the time period in which the disease becomes [...]
Multiple sclerosis: identifying and treating early symptoms can prevent multiple sclerosis diagnosis
Early treatment of the symptoms of multiple sclerosis (MS) may reduce the risk of a definitive diagnosis of the condition, or of relapse [...]
5 things a neurologist wants you to know about multiple sclerosis
Whether you’re newly diagnosed with multiple sclerosis (MS) or have had it for decades, you probably have some questions about the [...]
Treating multiple sclerosis early can bring benefits, delay relapses
Getting an early head start on treating multiple sclerosis (MS) may bring dividends years down the road, find a new study published [...]
Primary progressive multiple sclerosis (PPMS)
Primary progressive multiple sclerosis (PPMS) is an uncommon form of MS that affects approximately 10-15% of MS patients. In PPMS, [...]
MRI not a predictor of long-term multiple sclerosis outcomes
For patients with multiple sclerosis (MS), magnetic resonance imaging (MRI) and clinical assessments do not appear to offer long-term [...]
Antioxidant therapies seen as promising approach in treating multiple sclerosis and like diseases
A review article published in the British Journal of Pharmacology assesses antioxidant approaches for treating neurodegenerative [...]
Disease modifying drugs help protect multiple sclerosis patients with benign status from disability
Women with multiple sclerosis (MS) and people diagnosed with the disease at a younger age are more likely to have a benign course of MS, [...]
Finally, attention switches to progressive multiple sclerosis
Therapy for multiple sclerosis (MS) has been on a roll. Since 2009, a steady stream of more effective medications has been introduced for [...]
Multiple sclerosis risk higher in children and adolescents with type 1 diabetes: study
Multiple sclerosis (MS) risk is higher in children and adolescents with type 1 diabetes, according to research. Susanne Bechtold, M.D., a [...]
Scientists believe to discover ‘breakthrough’ cure for multiple sclerosis/type 1 diabetes
In a new study published in the journal Nature Communications, researchers at the University of Bristol claim that the diseases could be [...]
High depression rates in multiple sclerosis patients tied to brain inflammation in recent study
Inflammation in a brain region called the hippocampus might explain why patients with multiple sclerosis (MS) suffer from depression far [...]
9 approved multiple sclerosis therapies you should know about
1. Tysabri (Natalizumab) Natalizumab (manufactured by Biogen Idec as Tysabri; previously named Antegren) is a humanized monoclonal [...]
Multiple sclerosis patients’ personal circumstances largely shape their views on therapy preferences
Opinions voiced by multiple sclerosis (MS) patients as to what they most want from, and like in, an MS treatment differ widely, although [...]
Clean scans sustained with Siponimod in multiple scleorsis
An extension of the phase II BOLD study found sustained reductions in gadolinium-enhancing T1 and new or enlarging T2 lesions over 2 years [...]
ICER draft report evaluating therapies for RRMS now open for public comment
The Institute of Clinical and Economic Review (ICER) released the early draft of a paper intended to inform a future report evaluating [...]
Microbiome study reveals inflammatory pathways linked to multiple sclerosis
The collective microenvironment of gut bacteria, called the gut microbiome, has come to receive attention in many research labs for its [...]
High blood pressure in multiple sclerosis seen to increase risk of disability progression
High blood pressure may be linked to greater overall disability in people with multiple sclerosis (MS), although the rate at which [...]
Elevated BMI: a modifiable risk factor for multiple sclerosis?
Individuals with genetically increased body mass indexes were at a greater risk for developing multiple sclerosis (MS), according to [...]
Scientists develop a drug for the treatment of multiple sclerosis
A team of scientists has created a new form of a vaccine used for the treatment of multiple sclerosis, one of the most severe [...]
Micro-RNA levels may be diagnostic marker, distinguishing multiple sclerosis from other diseases
Patients with multiple sclerosis (MS) have higher levels of a micro-RNA called miR-150 in their cerebrospinal fluid, a liquid surrounding [...]
Multiple sclerosis-related optic neuropathy can be reversed with allergy drug (antihistamine): study
Multiple sclerosis-related optic neuropathy can be reversed with allergy drugs (antihistamines), according to research. The preliminary [...]
Multiple sclerosis development: what is clinically isolated syndrome (CIS)?
1. What is Clinically Isolated Syndrome? Clinically isolated syndrome (CIS) is often a sign of multiple sclerosis and the term refers to [...]
Four new risk genes associated with multiple sclerosis discovered
Scientists of the Technical University of Munich (TUM) and the Max Planck Institute of Psychiatry have identified four new risk genes that [...]
Clinical pilates seen to improve both cognition and muscle strength in multiple sclerosis patients
Clinical pilates can improve cognitive skills and life quality in multiple sclerosis (MS) patients, in addition to helping them physically. [...]
Sleep impacts cognitive function in multiple sclerosis patients
Obstructive sleep apnea and sleep disturbances are linked to diminished cognitive ability in patients with multiple sclerosis (MS), [...]
How does menopause affect women with multiple sclerosis?
Although menopause occurs in every woman who lives long enough, very little research has been done on its effects on women with multiple [...]
Gray matter atrophy tied to specific disabilities in multiple sclerosis
Specific disabilities in multiple sclerosis (MS) were associated with voxelwise gray matter loss in distinct locations, a cross-sectional [...]
Processed foods and additives may lead to multiple sclerosis, autoimmune diseases
Processed foods have been added to the list of “no-no” items that we are not supposed to eat if you, like me, are unfortunate enough to [...]
Multiple sclerosis therapy can ‘reverse disease’
A radical treatment can halt the progression of multiple sclerosis and even reverse symptoms of the autoimmune disease, research [...]
Immune ablation before stem cell transplant works in multiple sclerosis
A myeloablative protocol similar to those used in hematologic malignancies is feasible as a prelude to autologous hemapoietic stem cell [...]
‘Multiple sclerosis does not remit’ – call to change RRMS name to relapsing multiple sclerosis
MS does not remit and the out dated term causes many people to delay taking medication, says Dr Patricia Coyle, Founder and Director of [...]
Sluggish bowels may increase fatigue in multiple sclerosis
NATIONAL HARBOR, Md. -- Sluggish bowels may be contributing to fatigue among multiple sclerosis (MS) patients, according to a small study [...]
Immunotherapy-transplant combo works in multiple sclerosis
NATIONAL HARBOR, Md. -- A combination of high-dose immunosuppressive therapy and autologous hematopoietic cell transplantation resulted in [...]
Genetic link to multiple sclerosis found
For the first time, scientists say they’ve discovered a genetic mutation linked to a rare type of multiple sclerosis, and they are hoping [...]
Mitoxantrone may boost colon cancer risk in multiple sclerosis
Multiple sclerosis patients taking the drug mitoxantrone had a higher incidence of colorectal cancer and acute myeloid leukemia (AML) than [...]
Ankrd55: a new gene involved in multiple sclerosis is discovered
Multiple Sclerosis (MS) is a neurological disease, characterised by demyelination and the onset of chronic, neurodegenerative damage of the [...]
Today is World Multiple Sclerosis Day
According to WorldMSDay.org, World MS Day is officially marked every year on the last Wednesday of May. If you want to take part, [...]
Multiple sclerosis vs. stroke, differences in symptoms, causes, and treatments
Multiple sclerosis and stroke may seem like they don’t have much in common, but they both affect the brain and the nervous system and so [...]
Multiple sclerosis and young adult-onset hodgkin lymphoma may share underlying causes, study says
Previous studies suggested that multiple sclerosis (MS) andHodgkin lymphoma might share underlying causes, including exposure to [...]
Multiple sclerosis risk higher in rosacea-affected women: Sstudy
Multiple sclerosis risk has been found to be higher in rosacea-affected women. The study was conducted by researchers from the University [...]
Study of viral infection revives possibility of link between multiple sclerosis and viruses
Researchers investigating immune B-cell response to the Epstein-Barr virus (EBV) and cytomegalovirus (CMV) found that it may correlate with [...]
Children with and without multiple sclerosis have differences in gut bacteria
In a recent study, children with multiple sclerosis had differences in the abundance of specific gut bacteria than children without the [...]
Promising discovery for multiple sclerosis
CANADA – The study results published in the Journal of Experimental Medicine, found the involvement of a molecule in the development [...]
Search for progressive multiple sclerosis treatment is gathering momentum
Imagine suffering from blurred vision, regular headaches, numbness and tingling in your arms and legs, constantly feeling tired and [...]
Diet plays a role in multiple sclerosis progression through its impact on astrocytes, researchers say
Dietary habits and the composition of the gut flora can influence neuroinflammation and affect the outcome of neurodegenerative diseases [...]
Linking diet and intestinal flora with multiple sclerosis
US – New research from Brigham and Women’s Hospital Boston (USA) suggests that bacteria living in the gut are linked in the activity [...]
Vitamin D status during pregnancy and risk of multiple sclerosis in offspring
Study Summary Although adequate vitamin D levels have been linked to lower risk for multiple sclerosis (MS) in adulthood, previous [...]
Yoga may help reduce multiple sclerosis symptoms, says study
GENEVA: Yoga and aquatic exercise may reduce certain symptoms of multiple sclerosis (MS) such as fatigue, depression and paresthesia, a new [...]
At-home ‘brain training’ program for multiple sclerosis patients to improve cognitive skills by 29%
Multiple sclerosis patients using a cognitive remediation computer training program, part of a controlled trial by researchers from NYU [...]
Multiple sclerosis risk may increase with obesity in children and teens
Multiple sclerosis (MS) risk may increase with obesity in children and teens. The researchers suspect that the hormone leptin, responsible [...]
Urinary tract symptoms affect 70% of multiple sclerosis patients in study and contribute to disability
Urinary tract symptoms affect a large proportion of patients with multiple sclerosis (MS), yet their extent and type is not well-known. A [...]
Study associates obesity in youth, low Vitamin D levels with multiple sclerosis onset and progression
A systematic review of existing medical literature on multiple sclerosis (MS) could shed light on MS causes and predictors for disease [...]
Generic drug helps multiple sclerosis damage in mid-stage trial
A generic drug for allergy symptoms showed signs that it may help patients with multiple sclerosis rebuild their eye nerves, offering a [...]
5 multiple sclerosis treatment options
There are no specific therapies that can effectively cure patients with multiple sclerosis. However, there are a number of multiple [...]
Smoking appears linked to brain abnormalities in people with multiple sclerosis-related disease
A team of researchers suggested thatcigarette smoking is associated with adverse effects to white matter in the brain, and reported that [...]
In multiple sclerosis, brain damage may be repaired by blocking a certain brain enzyme
In multiple sclerosis (MS), brain damage may be repaired by blocking a certain brain enzyme. Coming from researchers at Oregon Health [...]
Taste sensory deficit underestimated in multiple sclerosis patients
Multiple sclerosis (MS) patients may exhibit taste sensory deficits more often than previously understood, according to [...]
Multiple sclerosis patients take part in survey of risk/benefit considerations in choosing treatments
The National Multiple Sclerosis Society is funding a new survey to understand how people living with multiple sclerosis (MS) weigh risks [...]
5 important tools in multiple sclerosis diagnosis
A thorough physical examination of the patient and knowledge of his or her medical history is a must in an accurate multiple sclerosis [...]
Multiple sclerosis treatment, faster MRI diagnosis method helps reduce brain inflammation
New multiple sclerosis treatment has been uncovered, along with faster MRI diagnosis method to help reduce brain inflammation. Researchers [...]
Young multiple sclerosis patients in United States more likely overweight & suffer relapses than peers – study
Scientists at the Pediatric MS Center at NYU Langone, New York, reported that U.S. adolescents with multiple sclerosis (MS) receiving [...]
Alemtuzumab (Lemtrada) seen to slow disease progression by targeting key brain systems
Several clinical trials have shown that alemtuzumab (Lemtrada) effectively reduces relapse rates in patients with multiple sclerosis [...]
Plant peptide could prevent onset of multiple sclerosis
MedUni Vienna has made a crucial development in the treatment of Multiple Sclerosis (MS): Together with his team and the research group led [...]
MRI could be used for multiple sclerosis diagnostics
Evidence of multiple sclerosis (MS) can be detected using magnetic resonance imaging (MRI) scanners in the near future, according to [...]
Multiple sclerosis: comorbidities common at diagnosis
Patients newly diagnosed with multiple sclerosis (MS) often have other chronic medical conditions, with fibromyalgia, inflammatory bowel [...]
Using adaptive yoga to battle multiple sclerosis
Yoga has long been considered an effective form of exercise to help the body and mind. But recently it' also become an important part of a [...]
5 potential side effects of multiple sclerosis medications
Possible side effects for multiple sclerosis (MS) medications can range from mild to life-threatening. When managing MS, health care [...]
New role of environment in multiple sclerosis revealed
Environmental factors may be playing a much greater role in the onset of multiple sclerosis (MS) than previously realised, according to [...]
Brain training video games ‘can soothe symptoms of multiple sclerosis’
Playing brain training video games can soothe symptoms of multiple sclerosis, say scientists. It boosts connections between neurons [...]
Can drinking lots of coffee lower risk for multiple scleorsis?
Coffee's possible health perks keep getting sweeter. In this case, a new study in the Journal of Neurology Neurosurgery & [...]
Ocrelizumab benefit in PPMS consistent in subgroups
NEW ORLEANS — A subgroup analysis of the phase 3 ORATORIO trial in primary progressive multiple sclerosis (PPMS) showed that ocrelizumab [...]
Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently
Walking with a wearable robotic exoskeleton may enable people with multiple sclerosis to walk more efficiently by reducing the energy and [...]
FDA grants breakthrough therapy for Ocrelizumab for PPMS
Press Release FDA grants Breakthrough Therapy Designation for GENENTECH’s investigational medicine ocrelizumab in primary progressive [...]
Multiple sclerosis patients may lose ability to taste
Many patients with multiple sclerosis (MS) lose the ability to distinguish different tastes -- a signal associated with MS-related lesions [...]
Multiple sclerosis study finds lipid antibodies reflect changes in brainvolume and lesions
Brigham and Women’s Hospital researchers reported that antibodies directed at lipids are associated with magnetic resonance imaging [...]
Multiple sclerosis patients seen to safely switch to oral drugs from injectable oral therapies
Stable multiple sclerosis (MS) patients do not appear to be at any increased risk of disease reactivation while switching to oral therapy [...]
Adaptive yoga for multiple sclerosis
Some people with multiple sclerosis decide to avoid yoga because they believe they won’t be able to do the poses or may feel [...]
New MRI technique offers faster diagnosis of multiple sclerosis
A new way of using MRI scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by researchers at The [...]
Beyond first-line: Natalizumab vs Fingolimod for RRMS
For patients with multiple sclerosis (MS) who are treated with injectable disease-modifying therapies (DMTs) for more than 2 years, the [...]
Study details source of mental problems associated with multiple sclerosis
A study out today sheds new light on multiple sclerosis (MS), specifically damage in the brain caused by the disease that may explain the [...]
No early risk when stable multiple sclerosis patients switch to oral drugs
No differences in relapse or progression rates between switchers & stayers over 6 months Multiple sclerosis patients who are well [...]
Epilepsy drug ‘could help multiple sclerosis patients’
An anti-convulsant drug used to treat epilepsy may also prevent nerve damage in patients with multiple sclerosis (MS), research has [...]
Multiple sclerosis (MS) patients showing progress with cancer treatment
The doctors in Sheffield England discovered that the treatment normally used for cancer patients has worked well with people that have [...]
Obstructive sleep apnea, sleep disorders may contribute to multiple sclerosis fatigue
Obstructive sleep apnea (OSA) and sleep disorders may contribute to multiple sclerosis fatigue. Sleep problems and lack of sleep is a [...]
Suppressing immune disorders in multiple sclerosis
There may be an easy way to treat immune related disorders in mice models of multiple sclerosis (MS), according to a study published in [...]
Multiple sclerosis occurrence in women three to four times more likely than men
Occurrence of multiple sclerosis in women is three to four times higher compared to men. Multiple sclerosis (MS) in women is usually [...]
Multiple sclerosis bladder control problems include incontinence and nocturia
Multiple sclerosis can cause bladder control problems like incontinence and nocturia. Bladder control problems are actually quite common in [...]
Multiple sclerosis eye problems: optic neuritis, nystagmus and diplopia
Multiple sclerosis (MS) can lead to many health complications including eye problems like optic neuritis, nystagmus and diplopia. Multiple [...]
Multiple sclerosis clinical trials more successful than other diseases
Clinical trials for multiple sclerosis (MS) therapies demonstrate a success rate that is nearly triple that of other diseases, with small [...]
High dose vitamin D could treat multiple sclerosis, scientists find
Taking large doses of the recommended daily dose of vitamin D could be a cheap and simple treatment for multiple sclerosis, say [...]
Can we vaccinate against PML in multiple sclerosis?
“Both active vaccination/treatment with major capsid protein VP1 of JC polyoma virus and passive vaccination/treatment with broadly [...]
MedDay misses endpoint in phase III multiple sclerosis vision loss trial
A Phase III trial of MedDay's multiple sclerosis drug has missed its primary endpoint. The drug, which made headlines in April when it [...]
Brain cell death may cause multiple sclerosis
Scientists say they’ve pinpointed the brain cell deaths that seem to trigger MS, and their research could lead to a new treatment. It [...]
New drug is first to treat Progressive Multiple Sclerosis
Studies show that ocrelizumab works for both the relapsing and progressive forms of MS. Symptoms come and go in most cases of multiple [...]
Poor visual symptoms in multiple sclerosis patients
Multiple sclerosis (MS) patients with histories of neuro-ophthalmic symptoms performed poorly on neuropsychological tasks, according to a [...]
Multiple sclerosis and the prevalence of sleep disorders, epileptic seizures
Sleep disorders and epileptic seizures are of higher prevalence in those with multiple sclerosis. Multiple sclerosis is a chronic disease [...]
Multiple sclerosis causes psychiatric symptoms
As a chronic neurological condition, it should come as no surprise that multiple sclerosis can produce psychiatric problems. In fact, [...]
Cellular target opens new pathway for multiple sclerosis therapy
MedicalResearch.com Interview with: Dr. Vittorio Gallo PhD Center for Neuroscience Research Children’s Research [...]
How multiple sclerosis can be triggered by brain cell death
Multiple sclerosis (MS) may be triggered by the death of brain cells that make the insulation around nerve fibers, a surprising new view [...]
Pregnancy hormone could keep multiple sclerosis at bay
Taking a pregnancy hormone staves off multiple sclerosis relapses, a small clinical trial suggests. The results hint at a potential [...]
Trigeminal neuralgia, type of nerve pain, is an early multiple sclerosis symptom
Trigeminal neuralgia affects the fifth cranial nerve, trigeminal, which is responsible for the sensation in the face involved with biting [...]
Exploring new paths for the treatment of multiple sclerosis
(Edmonton) Research from the University of Alberta's Faculty of Medicine & Dentistry is trailblazing a potential new pathway for the [...]
Biogen reports top-line results from phase 3 study evaluating Natalizumab in SPMS
Wednesday, October 21, 2015 7:31 am EDT CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Phase 3 ASCEND study investigating natalizumab in the [...]
EMD Serono announces publication of PRISMS-15 year follow-up study using Rebif in RRMS
Rockland, Massachusetts, October 12, 2015 – EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, today [...]
Treatment effects maintained over 5 years in patients with RRMS who received Lemtrada
Thursday, October 8, 2015 1:00 am EDT CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, aSanofi company, today announced positive new [...]
Genentech’s Ocrelizumab show positive pivotal study results in both RRMS and PPMS
Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primary Progressive [...]
EMD Serono announces recipients of the third annual €1 million grant for multiple sclerosis innovation
EMD Serono Announces Recipients of the Third Annual €1 Million Grant for Multiple Sclerosis Innovation Four research grants awarded [...]
Results from ZINBRYTA phase 3 DECIDE study presented at ECTRIMS
Results from ZINBRYTA™ (Daclizumab High-Yield Process) Phase 3 DECIDE Study Highlighting Efficacy Compared to Interferon Beta-1a [...]
New analysis suggests Aubagio slows brain atrophy in people with Relapsing MS
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis Additional MRI data on [...]
Data show effects of TECFIDERA in newly-diagnosed and early disease course multiple sclerosis patients
New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis [...]
Opexa announces granting of new t-cell patents covering tcelna
THE WOODLANDS, Texas--(BUSINESS WIRE)-- Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company developing personalized [...]
Genzyme introduces “vs.MS”, a global initiative
Genzyme Introduces vs.MS, a Global Initiative Aimed at Uncovering the Often Unspoken Challenges of MS to Drive Better Informed [...]
Genentech’s Ocrelizumab to show efficacy in people with PPMS in large phase III study
Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large [...]
Bayer receives FDA approval for BETACONNECT
Intended for U.S. Media Only Whippany, N.J., September 25, 2015 – Bayer HealthCare announced today that the U.S. Food and Drug [...]
Novartis acquires all remaining rights to GSK Ofatumumab to develop treatments for multiple sclerosis
Novartis acquires all remaining rights to GSK’s Ofatumumab to develop treatments for MS and other autoimmune indications Novartis [...]
EMD Serono and Opexa amend agreement to support ongoing development of Tcelna for multiple sclerosis
EMD Serono and Opexa Amend Agreement to Support Ongoing Development of Tcelna (imilecleucel-T) for Multiple Sclerosis Personalized [...]
Pfizer & Synthon enter Into U.S. commercialization agreement for treatment of multiple sclerosis
Pfizer Inc. and Synthon, an international pharmaceutical company specializing in the development of complex generic medicines, today [...]
FDA: Gadolinium-based MRI contrast agents pose possible brain risk
A statement from our CMSC leadership: While the implications for MS patient care may need to be re-evaluated and changed in the future [...]
Genentech’s Ocrelizumab reduced both relapses and disability progression versus Rebif
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif®) in Two Phase [...]
Sandoz announces US launch of Glatopa, the first generic competitor to Copaxone 20mg
Sandoz announces US launch of Glatopa™, the first generic competitor to Copaxone® 20mg Glatopa is the first FDA-approved, [...]
Novartis statement on reported case of PML
Novartis Statement on Reported Case of PML Novartis has been informed of a patient with progressive multifocal leukoencephalopathy [...]
FDA accepts biologics license application for ZINBRYTA for treatment of multiple sclerosis
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS BLA Acceptance Follows [...]
Mallinckrodt research fellowship award program announcement
Mallinckrodt Research Fellowship Award Program Announcement Mallinckrodt Pharmaceuticals is pleased to announce the Research Fellowship [...]
FDA accepts filing of BETACONNECT for RRMS patients taking BETASERON
FDA Accepts Filing of BETACONNECT™* for Relapsing-Remitting Multiple Sclerosis Patients Taking BETASERON® (interferon beta-1b) Offers [...]
International survey identifies opportunities for improving multiple sclerosis treatment satisfaction
International Survey from Biogen Identifies Opportunities for Improving MS Treatment Satisfaction Many Factors Influence Patient [...]
PLEGRIDY three-year data support long-term safety and efficacy in multiple sclerosis patients
PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple [...]
TECFIDERA Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients TECFIDERA Provides Robust and [...]
The FDA approves a generic form of Copaxone
The FDA Approves a Generic form of Copaxone® Thursday, April 16, 2015 The U.S. Food and Drug Administration has approved a generic [...]
People with multiple sclerosis may have trouble recognizing emotions
People with MS may have trouble recognizing emotions -- MS can damage parts of the brain that allow us to recognize emotions in others. [...]
EMA validates marketing authorization application for ZINBRYTA for treatment of multiple sclerosis
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of [...]
Teva Neuroscience & Access Health team up for special multiple sclerosis awareness show: thursday, 3/5
Teva Neuroscience & Access Health Team Up for Special MS Awareness Show: Thursday, March 5 As Multiple Sclerosis Awareness Week [...]
Multiple sclerosis paroxysmal symptoms confused with seizures due to sudden onset
Multiple sclerosis paroxysmal symptoms can be confused with seizures due to its sudden onset. Paroxysmal symptoms are unique to multiple [...]
How Vitamin D repairs myelin in multiple sclerosis
An international team of researchers have proposed how vitamin D repairs myelin in multiple sclerosis. This finding could lead to [...]
Acorda announces data from first clinical trial of remyelinating antibody in multiple sclerosis
Acorda Announces Safety and Tolerability Data from First Clinical Trial of Remyelinating Antibody in Multiple Sclerosis Phase 1 trial [...]
First multiple sclerosis patients in the U.S. receive Genzyme’s Lemtrada following FDA approval
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval – Lemtrada now available in the U.S. two weeks post [...]
Genzyme’s Lemtrada approved by the FDA
Genzyme’s Lemtrada Approved by the FDA - Approval Establishes Genzyme’s MS Franchise in the U.S. with Two Approved Products; Follows [...]
Genzyme announces enrollment of first patient in phase II Vatelizumab trial in RRMS
Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis Tuesday, November [...]
Results from two phase III studies added to U.S. label of Genzyme’s Aubagio
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio Once-daily Aubagio is the only oral treatment to [...]
At four years, treatment effect maintained in patients who received Lemtrada in studies
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies - In [...]
New international survey finds multiple sclerosis patients and neurologists view communication positively
New International Survey Finds MS Patients and Neurologists View Communication Positively, Yet Struggle to Discuss Key MS [...]
Biogen Idec’s PLEGRIDY approved in the US for the treatment of multiple sclerosis
Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis Friday, August 15, 2014 [...]
PLEGRIDY (Peginterferon beta-1a) approved in the EU for the treatment of multiple sclerosis
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis Wednesday, July 23, 2014 [...]
Teva files citizen petition with the US FDA regarding the complexity of COPAXONE
Teva files Citizen Petition with the U.S. Food and Drug Administration (FDA) regarding the Complexity of COPAXONE® (Glatiramer Acetate) [...]
Genzyme’s Lemtrada approved in Argentina for treatment of multiple sclerosis
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis Monday, June 30, 2014 8:00 am EDT CAMBRIDGE, [...]
Biogen Idec and AbbVie Announce Results from Phase 3 Study Investigating Daclizumab
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple [...]
Genzyme’s Lemtrada resubmission accepted for review by FDA
Genzyme’s Lemtrada Resubmission Accepted for Review by FDA - Agency action expected in Q4 2014 - Cambridge, Mass. - May 30, 2014 - [...]
Data from Biogen Idec’s portfolio of multiple sclerosis therapies and pipeline featured at congresses
Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses Friday, May 30, 2014 [...]
Biogen Idec announces official partnership with Sailing Sclerosis’ “Oceans of Hope”
Biogen Idec Announces Official Partnership with Sailing Sclerosis Oceans of Hope to Globally Change Perceptions of MS Wednesday, May [...]
Genzyme recognizes sixth annual World MS Day
Genzyme Recognizes Sixth Annual World MS Day - Company Supporting Wide Range of Programs to Help Improve the Lives of People Living with [...]
CHMP adopts positive opinion for PLEGRIDY as a treatment for multiple sclerosis in the EU
CHMP Adopts Positive Opinion for PLEGRIDY™ (Peginterferon Beta-1a) as a Treatment for Multiple Sclerosis in the European Union Friday, [...]
Opexa reaches enrollment target in phase IIb trial of personalizedimmunotherapy for SPMS
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple [...]
Teva announces COPAXONE recognized as “Brand of the Year” by Pharm Exec Magazine
Teva announces COPAXONE® recognized as Brand of the Year by Pharmaceutical Executive Magazine JERUSALEM--(BUSINESS WIRE)--May 8, [...]
New TYSABRI analysis shows improved walking speed in significant number of multiple sclerosis patients
New TYSABRI® Analysis at AAN Annual Meeting Shows Improved Walking Speed in Significant Number of MS Patients Thursday, May 1, 2014 [...]
New data reinforce efficacy of TECFIDERA in multiple sclerosis patients with high disease activity
New Data Reinforce Efficacy of TECFIDERA® (Dimethyl Fumarate) in MS Patients with High Disease Activity Wednesday, April 30, 2014 7:30 [...]
Slowing of brain atrophy sustained at three years in patients treated with Lemtrada
Slowing of Brain Atrophy and Reductions in New Multiple Sclerosis Lesions Sustained at Three Years in Patients Treated with Genzyme’s [...]
Genzyme announces multi-year multiple sclerosis research collaboration with academic medical center
Genzyme Announces Multi-Year Multiple Sclerosis Research Collaboration with Leading Academic Medical Center Wednesday, April 30, 2014 [...]
Teva announces supreme court denial of request for interim relief to stay
Teva Announces Supreme Court Denial of Request for Interim Relief to Stay Court of Appeals Ruling for Copaxone® Patent Due to the [...]
Biogen Idec to present new clinical data at AAN Annual Meeting
Biogen Idec to Present New Clinical Data from its Robust Neurology Portfolio at AAN Annual Meeting Monday, April 14, 2014 7:30 am [...]
